Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Pharmacol Ther. 2009 Oct;86(4):438-41. doi: 10.1038/clpt.2009.166. Epub 2009 Aug 26.

Imaging and biomarkers in early Alzheimer's disease and mild cognitive impairment.

Author information

  • 1Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. peter8@mayo.edu

Abstract

A major focus of research on aging and dementia pertains to the prediction of future cognitive decline. Toward this end, several longitudinal studies are under way that are designed to explore early predictors of cognitive impairment. Neuroimaging techniques and biomarkers have shown promise in this application. Ultimately, it is likely that the use of a combination of neuroimaging and chemical biomarkers will be involved in predicting the development of dementia and Alzheimer's disease (AD).

PMID:
19710641
[PubMed - indexed for MEDLINE]
PMCID:
PMC3098135
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley Icon for PubMed Central
    Loading ...
    Write to the Help Desk